These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9384711

  • 1. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
    Or R, Kalinkovich A, Nagler A, Weisman Z, Naparstek E, Weiss L, Hahn T.
    Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
    [Abstract] [Full Text] [Related]

  • 2. Serum cytokine levels in patients undergoing bone marrow transplantation.
    Chasty RC, Lamb WR, Gallati H, Roberts TE, Brenchley PE, Yin JA.
    Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
    [Abstract] [Full Text] [Related]

  • 3. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 4. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J, Zhao Q, Yao H.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
    [Abstract] [Full Text] [Related]

  • 5. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T.
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [Abstract] [Full Text] [Related]

  • 6. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A, Barak V, Novick D, Nagler A.
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
    Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Prato B, Prontera C, Facchini V, Genazzani AR.
    Anticancer Res; 1996 Sep; 16(5B):3125-8. PubMed ID: 8920779
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J.
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [Abstract] [Full Text] [Related]

  • 9. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
    Tur-Kaspa I, Maor Y, Weissenberg R, Madgar I, Aderka D, Dor J, Mashiach S, Wallach D.
    J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606
    [Abstract] [Full Text] [Related]

  • 10. Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT.
    Alessandrino EP, Bernasconi P, Colombo A, Boni M, Bonfichi M, Caldera D, Bernasconi C.
    Bone Marrow Transplant; 1991 Apr; 7 Suppl 2():51. PubMed ID: 1878716
    [No Abstract] [Full Text] [Related]

  • 11. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Apr; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 12. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
    Shen R, Xu CG, Li LZ, Zhang T, Qin XM, Li J, Zhao CL.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
    [Abstract] [Full Text] [Related]

  • 13. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M, Iwai H, Naiki T, Ohnishi H, Muto Y, Moriwaki H.
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [Abstract] [Full Text] [Related]

  • 14. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 15. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP, Gratama JW, Lamers C, van Esser JW, Bolhuis RL, Cornelissen JJ.
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [Abstract] [Full Text] [Related]

  • 16. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, Gusmano R, Borrone C, Pistoia V.
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [Abstract] [Full Text] [Related]

  • 17. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
    Sumitomo M, Suda S, Shindo K, Fukumura M, Fukushima J, Okuda K, Ito A.
    Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
    [Abstract] [Full Text] [Related]

  • 18. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
    Maier B, Lehnert M, Laurer HL, Mautes AE, Steudel WI, Marzi I.
    Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
    [Abstract] [Full Text] [Related]

  • 19. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
    Modzelewski B.
    Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
    [Abstract] [Full Text] [Related]

  • 20. Increase of sTNF receptor levels in acute renal allograft rejection after treatment with OKT3.
    Bemelman FJ, Jansen J, van der Poll T, van Deventer SJ, ten Berge RJ.
    Nephrol Dial Transplant; 1994 Jan; 9(12):1786-90. PubMed ID: 7708265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.